Related references
Note: Only part of the references are listed.Microglial inflammasome activation drives developmental white matter injury
Rebecca K. Holloway et al.
GLIA (2021)
Assessing Autophagy in Microglia: A Two-Step Model to Determine Autophagosome Formation, Degradation, and Net Turnover
Ainhoa Plaza-Zabala et al.
FRONTIERS IN IMMUNOLOGY (2021)
Fascin-1 is Highly Expressed Specifically in Microglia After Spinal Cord Injury and Regulates Microglial Migration
Shuisheng Yu et al.
FRONTIERS IN PHARMACOLOGY (2021)
Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model
Kevin Clayton et al.
MOLECULAR NEURODEGENERATION (2021)
Lipopolysaccharide induces neuroinflammation in microglia by activating the MTOR pathway and downregulating Vps34 to inhibit autophagosome formation
Xiaoxia Ye et al.
JOURNAL OF NEUROINFLAMMATION (2020)
The role of sphingolipids in endoplasmic reticulum stress
Woo-Jae Park et al.
FEBS LETTERS (2020)
Does Siponimod Exert Direct Effects in the Central Nervous System?
Markus Kipp
CELLS (2020)
TNF Production and Release from Microglia via Extracellular Vesicles: Impact on Brain Functions
Stefano Raffaele et al.
CELLS (2020)
pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis
David Kremer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS
Mariangeles Kovacs et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Sofie Voet et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Disease-Associated Microglia: A Universal Immune Sensor of Neurodegeneration
Aleksandra Deczkowska et al.
CELL (2018)
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
Ludwig Kappos et al.
LANCET (2018)
Spinal CXCL9 and CXCL11 are not involved in neuropathic pain despite an upregulation in the spinal cord following spinal nerve injury
Xiao-Bo Wu et al.
MOLECULAR PAIN (2018)
Cytokine signaling in multiple sclerosis: Lost in translation
Kerstin Goebel et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Interferon β for Multiple Sclerosis
Dejan Jakimovski et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Cytokine signaling in multiple sclerosis: Lost in translation
Kerstin Goebel et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ plus TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10)
Starlee Lively et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
RNA-Seq transcriptomic profiling of primary murine microglia treated with LPS or LPS plus IFNγ
Marta Pulido-Salgado et al.
SCIENTIFIC REPORTS (2018)
Unique microglia recovery population revealed by single-cell RNAseq following neurodegeneration
Tuan Leng Tay et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
IFN-β Plays Both Pro- and Anti-inflammatory Roles in the Rat Cardiac Fibroblast Through Differential STAT Protein Activation
Samir Bolivar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Microglial repopulation resolves inflammation and promotes brain recovery after injury
Rachel A. Rice et al.
GLIA (2017)
Pharmacokinetics, safety, and tolerability of siponimod (BAF312) in subjects with severe renal impairment: A single-dose, open-label, parallel-group study
Anne Gardin et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2017)
New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
Chih-Chung Lin et al.
JOURNAL OF IMMUNOLOGY (2017)
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis
Marcus Sucksdorff et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Effect of nitric oxide to axonal degeneration in multiple sclerosis via downregulating monocarboxylate transporter 1 in oligodendrocytes
Xiaoyi Tang et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Therapeutic inhibition of soluble brain TNF promotes remyelination by increasing myelin phagocytosis by microglia
Maria Karamita et al.
JCI INSIGHT (2017)
Microglial M1/M2 polarization and metabolic states
Ruben Orihuela et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
Antonietta Gentile et al.
JOURNAL OF NEUROINFLAMMATION (2016)
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures
Catherine O'Sullivan et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
Francesca Ronchi et al.
NATURE COMMUNICATIONS (2016)
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study
Ludwig Kappos et al.
JAMA NEUROLOGY (2016)
The therapeutic potential of interleukin-10 in neuroimmune diseases
A. J. Kwilasz et al.
NEUROPHARMACOLOGY (2015)
The neutralizing antibody GNbAC1 abrogates HERV-W envelope protein-mediated oligodendroglial maturation blockade
David Kremer et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process
M. Bonora et al.
CELL DEATH AND DIFFERENTIATION (2014)
Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
Silvia Rossi et al.
MOLECULAR NEURODEGENERATION (2014)
Human Endogenous Retrovirus Type W Envelope Protein Inhibits Oligodendroglial Precursor Cell Differentiation
David Kremer et al.
ANNALS OF NEUROLOGY (2013)
Fingolimod phosphate promotes the neuroprotective effects of microglia
Hiromi Noda et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Fingolimod modulates microglial activation to augment markers of remyelination
Samuel J. Jackson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
TNF-α potentiates glutamate-induced spinal cord motoneuron death via NF-κB
Laia Tolosa et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2011)
Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
Irena Dujmovic et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2009)
Divergent syntheses of all stereoisomers of phytosphingosine and their use in the construction of a ceramide library
Jeong-Ju Park et al.
BIOORGANIC CHEMISTRY (2008)
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Marco Prinz et al.
IMMUNITY (2008)
The type IIFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dual role of CD38 in microglial activation and activation-induced cell death
Lior Mayo et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program
Azeb Tadesse Argaw et al.
JOURNAL OF IMMUNOLOGY (2006)
TLR signaling tailors innate immune responses in human microglia and astrocytes
CS Jack et al.
JOURNAL OF IMMUNOLOGY (2005)
Cytokines in multiple sclerosis: from bench to bedside
J Imitola et al.
PHARMACOLOGY & THERAPEUTICS (2005)
TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures:: neuroprotection by NFκB inhibition
JY Zou et al.
BRAIN RESEARCH (2005)
TNF-induced death of adult human oligodendrocytes is mediated by c-jun NH2-terminal kinase-3
A Jurewicz et al.
BRAIN (2003)
Microglial activation state and lysophospholipid acid receptor expression
CS Tham et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
Expression and regulation of interleukin-10 and interleukin-10 receptor in rat astroglial and microglial cells
A Ledeboer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
The role of nitric oxide in multiple sclerosis
KJ Smith et al.
LANCET NEUROLOGY (2002)
Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis
DJ Cua et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
